Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(22%)
Results Posted
200%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
8
89%
Ph phase_2
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(1)
Terminated(1)
Other(3)

Detailed Status

unknown3
Not yet recruiting2
Recruiting1
Completed1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

unknown333%
recruiting111%
not_yet_recruiting222%
completed111%
active_not_recruiting111%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
9